Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy
- Status
- UNKNOWN
- Phase
- N/A
Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- NA
Haplo-identical SCT for High Risk (HR) Hematologic Malignancies w/Post-Transplant In-Vivo T-cell Depletion
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Reduced Intensity Conditioning (RIC) Regimen and Post-transplant Cyclophosphamide in Haploidentical Bone Marrow Transplantation in in Patients With Poor Prognosis Lymphomas
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY2835219 in Japanese Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb
- Status
- COMPLETED
- Phase
- PHASE2
Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
- Status
- COMPLETED
- Phase
- PHASE2
LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab
- Status
- COMPLETED
- Phase
- PHASE1
Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Mass Balance, Pharmacokinetics and Metabolism Study of IXAZOMIB
- Status
- COMPLETED
- Phase
- PHASE1